P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: LEGEND: a phase 1/2 study of EG-70 (detalimogene voraplasmid), a novel, non-viral intravesical gene therapy for patients with BCG-unresponsive non-muscle invasive bladder cancer with ca